Effects of traditional Chinese medicine polysaccharides on chronic diseases by modulating gut microbiota: A review

被引:3
作者
Li, Xinyu [1 ]
Zhu, Riran [2 ]
Liu, Qian [1 ]
Sun, Henglai [1 ]
Sheng, Huagang [1 ,3 ]
Zhu, Liqiao [1 ,3 ]
机构
[1] Shandong Univ Tradit Chinese Med, Coll Pharm, Jinan 250355, Peoples R China
[2] Shandong Univ Tradit Chinese Med, Affiliated Hosp, Jinan 250011, Peoples R China
[3] Shandong Univ Tradit Chinese Med, Key Lab Tradit Chinese Med Class Theory, Minist Educ, Jinan 250355, Peoples R China
关键词
Traditional Chinese medicine polysaccharides; Chronic diseases; Inflammatory bowel disease; Gut microbiota; Obesity; Type 2 diabetes mellitus; Liver diseases; Cancer; CHAIN FATTY-ACIDS; INDUCED ULCERATIVE-COLITIS; GANODERMA-LUCIDUM POLYSACCHARIDES; SODIUM-INDUCED COLITIS; DIET-INDUCED OBESITY; INTESTINAL MICROBIOTA; INSULIN-RESISTANCE; OXIDATIVE STRESS; LIVER-DISEASE; SOLUBLE POLYSACCHARIDE;
D O I
10.1016/j.ijbiomac.2024.136691
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Intestinal tract is the largest immune system of human body. Gut microbiota (GM) can produce a large number of metabolites, such as short-chain fatty acids and bile acids, which regulate the physiological health of the host and affect the development of disease. In recent years, traditional Chinese medicine (TCM) polysaccharides have attracted extensive attention with multiple biological activities and low toxicity. TCM polysaccharides can promote the growth of intestinal beneficial bacteria and inhibit the growth of harmful bacteria by regulating the structure and function of GM, thus playing a crucial role in preventing or treating chronic diseases such as inflammatory bowel disease (IBD), obesity, type 2 diabetes mellitus (T2DM), liver diseases, cancer, etc. In this paper, the research progress of TCM polysaccharides in the treatment of chronic diseases such as inflammatory bowel disease, obesity, T2DM, liver diseases, cancer, etc. by modulating GM was reviewed. Meanwhile, this review makes an in-depth discussion on the shortcomings of the research of TCM polysaccharides on chronic diseases by modulating GM, and new valuable prospection for the future researches of TCM polysaccharides are proposed, which will provide new ideas for the further study of TCM polysaccharides.
引用
收藏
页数:33
相关论文
共 311 条
  • [1] Polysaccharide from Smilax glabra Roxb Mitigates Intestinal Mucosal Damage by Therapeutically Restoring the Interactions between Gut Microbiota and Innate Immune Functions
    Abaidullah, Muhammad
    La, Shaokai
    Liu, Mengqi
    Liu, Boshuai
    Cui, Yalei
    Wang, Zhichang
    Sun, Hao
    Ma, Sen
    Shi, Yinghua
    [J]. NUTRIENTS, 2023, 15 (19)
  • [2] RETRACTED: Bachu Mushroom Polysaccharide Alleviates Colonic Injury by Modulating the Gut Microbiota (Retracted Article)
    Abdureyim, Zumrat
    Wang, Lei
    Tao, Qing
    Xu, Jing
    Yimiti, Delixiati
    Gao, Qian
    [J]. COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2022, 2022
  • [3] Considering gut microbiota in treatment of type 2 diabetes mellitus
    Adeshirlarijaney, Aneseh
    Gewirtz, Andrew T.
    [J]. GUT MICROBES, 2020, 11 (03) : 253 - 264
  • [4] Gut microbiota-derived metabolites as central regulators in metabolic disorders
    Agus, Allison
    Clement, Karine
    Sokol, Harry
    [J]. GUT, 2021, 70 (06) : 1174 - 1182
  • [5] ALAGBAOSO Chidube Anthony, 2022, Arq. Gastroenterol., V59, P288, DOI [10.1590/S0004-2803.202202000-51, 10.1590/s0004-2803.202202000-51]
  • [6] Antibiotics, gut microbiota, and Alzheimer's disease
    Angelucci, Francesco
    Cechova, Katerina
    Amlerova, Jana
    Hort, Jakub
    [J]. JOURNAL OF NEUROINFLAMMATION, 2019, 16 (1)
  • [7] Chitosan-modified Phellinus igniarius polysaccharide PLGA nanoparticles ameliorated inflammatory bowel disease
    Bai, Xinxin
    Feng, Zian
    Peng, Song
    Zhu, Tianyu
    Jiao, Lina
    Mao, Ningning
    Gu, Pengfei
    Liu, Zhenguang
    Yang, Yang
    Wang, Deyun
    [J]. BIOMATERIALS ADVANCES, 2022, 139
  • [8] Polysaccharides from small black soybean alleviating type 2 diabetes via modulation of gut microbiota and serum metabolism
    Bai, Zhouya
    Huang, Xiaojun
    Wu, Guangjie
    Zhang, Yanli
    Xu, Hedi
    Chen, Yang
    Yang, Huayu
    Nie, Shaoping
    [J]. FOOD HYDROCOLLOIDS, 2023, 141
  • [9] Prevention of chronic disease in the 21st century: elimination of the leading preventable causes of premature death and disability in the USA
    Bauer, Ursula E.
    Briss, Peter A.
    Goodman, Richard A.
    Bowman, Barbara A.
    [J]. LANCET, 2014, 384 (9937) : 45 - 52
  • [10] Pharmacological and metagenomics evidence of polysaccharide from Polygonum multiflorum in the alleviation of insulin resistance
    Bi, Qian
    Gu, Wen
    Meng, Fanying
    Yang, Xingxin
    Zeng, Linxi
    Liang, Li
    Yang, Min
    Zhang, Ting
    Yu, Jie
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2020, 164 : 1070 - 1079